adhd presentation

70
ADHD Diagnosis & Pharmacological Management Lori Dewey, MSN, PMHCNS - BC September 2014

Upload: lori-dewey

Post on 16-Jul-2015

55 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ADHD presentation

ADHDDiagnosis &

Pharmacological Management

Lori Dewey, MSN, PMHCNS-BC

September 2014

Page 2: ADHD presentation

Objectives

Understand the screening and diagnosis of ADHD

Develop knowledge of common medications used to treat ADHD in adults

Know the indications, dosage ranges, mechanisms of actions, monitoring, and contraindications of medications used to treat ADHD

Page 3: ADHD presentation

ADHD Defined

ADHD is a problem with inattentiveness, over-activity, impulsivity, or a combination these

– http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002518/

Page 4: ADHD presentation

Inattentive Symptoms

Fails to give close attention to details or makes careless mistakes in schoolwork

Has difficulty keeping attention during tasks or play Does not seem to listen when spoken to directly Does not follow through on instructions and fails to finish

schoolwork, chores, or duties in the workplace Has difficulty organizing tasks and activities Avoids or dislikes tasks that require sustained mental

effort (such as schoolwork) Often loses toys, assignments, pencils, books, or tools

needed for tasks or activities Is easily distracted Is often forgetful in daily activities

Page 5: ADHD presentation

Hyperactivity Symptoms(More likely in children)

Fidgets with hands or feet or squirms in seat

Leaves seat when remaining seated is expected

Runs about or climbs in inappropriate situations

Has difficulty playing quietly

Is often "on the go," acts as if "driven by a motor," talks excessively

Page 6: ADHD presentation

Impulsivity Symptoms

Blurts out answers before questions have been completed

Has difficulty awaiting turn

Interrupts or intrudes on others (butts into conversations or games)

– http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002518/

Page 7: ADHD presentation

Diagnosis

Screening tool:

– Adult ADHD Self-Report Scale (ASRS-v1.1)

http://www.help4adhd.org/documents/adultadhdselfreportscale-asrs-v1-1.pdf

Page 8: ADHD presentation

DSM IV Criteria

A. Either (1) or (2)1) Six or more of the following symptoms of inattention have persisted for at least six months to a

degree that is maladaptive and inconsistent with the developmental level:

Inattention

often fails to give close attention to details or makes careless mistakes in schoolwork, work, or other activities

often has difficulty sustaining attention in tasks or play activities often does not seem to listen when spoken to directly often does not follow through on instructions and fails to finish schoolwork, chores, or duties in

the workplace (not due to oppositional behaviour or failure of comprehension) often has difficulty organizing tasks and activities often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such

as schoolwork or homework) often loses things necessary for tasks or activites at school or at home (e.g. toys, pencils, books,

assignments) is often easily distracted by extraneous stimuli if often forgetful in daily activities

Page 9: ADHD presentation

DSM IV Criteria Cont.

2) Six or more of the following symptoms of hyperactivity-impulsivity have persisted for at least 6 months to a degree that is maladaptive and inconsistent with the developmental level:

Hyperactivity often fidgets with hands or feet or squirms in seat often leaves seat in classroom or in other situations in which remaining

seated is expected often runs about or climbs excessively in situations in which it is

inappropriate (in adolescents or adults, may be limited to subjective feelings of restlessness)

often has difficulty playing or engaging in leisure activities quietly often talks excessively is often 'on the go' or often acts as if 'driven by a motor'Impulsivity often has difficulty awaiting turn in games or group situations often blurts out answers to questions before they have been completed often interrupts or intrudes on others, e.g. butts into other children's games

Page 10: ADHD presentation

DSM IV Criteria Cont.

B. Some hyperactivity - impulsive or inattentive symptoms that cause impairment were present before the age of 7 years.

C. Some impairment from the symptoms is present in more than two or more settings (e.g. at school or work or at home).

D. There must be clear evidence of clinically significant impairment in social, academic, or occupational functioning.

E. The symptoms do not occur exclusively during the course of a Pervasive Developmental Disorder, Schizophrenia, or other Psychotic Disorder, and are not better accounted for by another mental disorder (e.g. Mood Disorder, Anxiety Disorder, Dissociative Disorder, or a Personality Disorder).

Based on these criteria, three types of ADHD are identified: ADHD, Combined Type: if both criteria 1A and 1B are met for the past 6 months ADHD, Predominantly Inattentive Type: if criterion 1A is met but criterion 1B is not

met for the past six months ADHD, Predominantly Hyperactive-Impulsive Type: if Criterion 1B is met but

Criterion 1A is not met for the past six months.

Page 11: ADHD presentation

Treatment

Behavioral and cognitive therapies

– Focused on reducing impulsivity and reinforcing positive long-term habits

Pharmacological management

– Stimulants

– Non-stimulants

Page 12: ADHD presentation

Treatment

Stimulants:

– Adderall and Adderall XR

– Vyvanse

– Ritalin and Ritalin LA

– Daytrana

– Concerta

– Focalin and Focalin XR

Non-stimulants:

– Strattera

– Wellbutrin

– Tenex

– Intuniv – no adult dosing available

– Clonidine

– Kapvay – no adult dosing available

Page 13: ADHD presentation

Stimulants

Monitor mood symptoms:

– Depression

– Anxiety

– Agitation

– Psychosis

– Emotional lability

– Exacerbation of bipolar sx

Page 14: ADHD presentation

Stimulants

Monitor LFTs

Short acting stimulants have a higher potential for abuse and more street value than longer acting stimulants

All stimulants carry a black box warning of potential drug dependence and abuse

Collaborate care with other providers/specialists for ptwith CV diseases/disorders, HTN, seizure disorders, liver impairment, etc

Caution with drugs that inhibit metabolism of stimulants

– Especially Prozac

Page 15: ADHD presentation

Stimulants

Adderall XR, Ritalin LA, Focalin, and Vivanse may be opened up and sprinkled on food

Vyvanse capsule may be dissolved in water

Page 16: ADHD presentation

Adderall

Adderall (dextroamphetamine/amphatimine)

– Dosage forms: 5, 7.5, 10, 12.5, 15, 20, 30mg

– 5-40 mg/day PO divided qd-tid

– Start 5 mg po qam or bid

– Increase 5 mg/day qwk

– Dose 4-6 hours apart

– Doses >40 mg rarely more effective

Page 17: ADHD presentation

Adderall

BLACK BOX WARNING: HIGH ABUSE POTENTIAL, DEPENDENCY

– SERIOUS CARDIOVASCULAR ADVERSE EVENTS & SUDDEN DEATH REPORTED WITH MISUSE

Page 18: ADHD presentation

Adderall

^^ dopamine & norepinephrine in the presynaptic neuron

– More robust in it’s action

– ^^ incidence of side effects

– Highly abused

– Works well at low doses

– Good for someone with no hx of mood disorders or substance abuse

Page 19: ADHD presentation

Adderall

Caution with: cardiovascluar disease, HTN, arrhythmias, drug abuse hx, psychosis, bipolar, depression, Tourettes/tics, seizures

May cause dysthymia

Side effects are dose dependent

^^ GI effects if taken on an empty stomach

Avoid abrupt withdrawal

Page 20: ADHD presentation

Adderall

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 21: ADHD presentation

Adderall XR

Adderall XR (dextroamphetamine/amphatimine)

– Dosage forms: 5, 10, 15, 20, 25, 30mg ER

– Start 20 mg i po qam

– Increase 10 mg/day q week

– Maximum dose: 60 mg/day

– 6-10 hour duration

– May augment with IR

Page 22: ADHD presentation

Adderall XR

BLACK BOX WARNING: HIGH ABUSE POTENTIAL, DEPENDENCY

– SERIOUS CARDIOVASCULAR ADVERSE EVENTS & SUDDEN DEATH REPORTED WITH MISUSE

Page 23: ADHD presentation

Adderall XR

Caution with:

cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Avoid abrupt withdrawal

Page 24: ADHD presentation

Adderall XR

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 25: ADHD presentation

Vyvanse

Vyvanse (lisdexamfetamine)

– Dosage forms: 20, 30, 40, 50, 60, 70 mg

– 30 mg po qam

– Increase 10-20 mg/day q week

– Maximum dose: 70 mg/qd

– Use lowest effective dose

– Molecules dissolve in the stomach. Less street value

– Difficult to get insurance to cover

Page 26: ADHD presentation

Vyvanse

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 27: ADHD presentation

Vyvanse

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

– Hyperhydrosis

Page 28: ADHD presentation

Ritalin

Ritalin (methylphenidate)

– Dosage forms: 5, 10, 20 mg

– Start 5-10 mg po bid

– Increase 10 mg/day q week

– May be dosed bid-qid

– Duration: 3-5 hours

– Give 30-45 min before meals

– Last dose before 6 pm

Page 29: ADHD presentation

Ritalin

BLACK BOX WARNING: DRUG DEPENDENCE

Page 30: ADHD presentation

Ritalin

Avoid use within 14 days of MAOI

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 31: ADHD presentation

Ritalin

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 32: ADHD presentation

Ritalin LA

Ritalin LA (methylphenidate)

– Dosage forms: 10, 20, 30, 40 mg ER

– Start 20mg po qam

– Increase 10 mg/day q week

– Maximum dose: 60 mg/qd

– Duration: 8-20 hours

– Do not crush or chew

Page 33: ADHD presentation

Ritalin LA

BLACK BOX WARNING: DRUG DEPENDENCE

Page 34: ADHD presentation

Ritalin LA

Avoid use within 14 days of MAOI

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 35: ADHD presentation

Ritalin LA

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 36: ADHD presentation

Daytrana

Daytrana (methylphenidate transdermal)– Dosage forms: 10, 15, 20, 30/9 h patch

– Apply 1 patch qd x 9h. Off 15h

– Start 10mg/9h patch qd x 9h off x 15 h

– Increase next size patch q week

– Maximum dose: 30 mg/9 h patch qd

– Apply 2 h before desired effect

– Drug effects may persist 5 hours after removal

– Use same titration when converting from po

– Do not alter/cut patch

Page 37: ADHD presentation

Daytrana

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 38: ADHD presentation

Daytrana

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

– ALT/AST elevation

Page 39: ADHD presentation

Concerta

Concerta (methylphenidate) – long acting ritalin

– Dosage forms: 18, 27, 36, 54 ER

– Dose: 18-72 mg po qam

– Start 18-36 mg po qd

– Increase by 18 mg/day q wk

– Maximum dose: 72 mg/day. May be dosed bid in some cases

– Duration: 8-12 hours

– Do not cut, crush or chew

– Dissolves in stomach in layers

– Less potent effect. Only effects dopamine. More tolerable in ptwith emotional problems

Page 40: ADHD presentation

Concerta

BLACK BOX WARNING: DRUG DEPENDENCE

– CHRONIC ABUSE MAY LEAD TO MARKED TOLERANCE AND PSYCHOLOGICAL DEPENDENCE

Page 41: ADHD presentation

Concerta

Avoid use within 14 days of MAOI

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 42: ADHD presentation

Concerta

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 43: ADHD presentation

Focalin

Focalin (dexmethylphenidate)

– Pure molecule of ritalin

– Dosage forms: 2.5, 5, 10 mg

– Start 2.5 mg po bid

– Increase 5-10 mg/day q week

– Maximum dose: 20 mg/day

– Difficult to get insurance to cover

– To convert from methylphenidate:

Start at 50% of current methylphenidate daily dose

Page 44: ADHD presentation

Focalin

BLACK BOX WARNING: DRUG DEPENDENCE

Page 45: ADHD presentation

Focalin

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 46: ADHD presentation

Focalin

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 47: ADHD presentation

Focalin XR

Focalin XR (dexmethylphenidate)

– Dosage forms: 5, 10, 15, 20, 25, 30, 35, 40 mg ER

– Start 10 mg po q am

– Increase 10mg/day q week

– Maximum dose: 40 mg/day

– To convert from IR form use same same daily dose. To convert from methylphenidate start at 50% of current methylphenidate daily dose

– Do not crush/cut/chew

Page 48: ADHD presentation

Focalin XR

BLACK BOX WARNING: DRUG DEPENDENCE

Page 49: ADHD presentation

Focalin XR

Caution with: cardiovascluar disease/arrhythmias

HTN

drug abuse hx

psychosis

bipolar

Tourettes/tics

seizures

Page 50: ADHD presentation

Focalin XR

Common side effects:

– Loss of appetite/weight loss

– Dry mouth

– Difficulty sleeping

– Headaches

– Abdominal pain, nausea, vomiting

– Temporary increases in blood pressure

– Emotional changes

– Increased heart rate

Page 51: ADHD presentation

Strattera

Strattera (atomoxetine)

– NON STIMULANT

– May take up to 4-6 weeks to see results

– Dosage forms: 10, 18, 25, 40, 60, 80, 100 mg

– Start 40 mg po qam x 3 days

– Increase to 80 mg/day

– May increase to 100 mg/day after 2 weeks if needed

– Maximum dose: 100 mg/qd

– Requires slower titration if pt is poor CYP2D6 metabolizer or on strong CYP2D6 inhibitor

– Norepinephrine reuptake inhibitor

– Doses >40 mg/day may be divided bid

– Dosing accd to weight= 0.5-1.4 mg/kg/day

Page 52: ADHD presentation

Strattera

Avoid use within 14 days of MAOI cardiovascluar disease/arrhythmias

HTN/hypotension

tachycardia

hepatic impairment

depression

bipolar

Page 53: ADHD presentation

Strattera

Common side effects:– Headache

– Dizziness

– Loss of appetite/weight loss/dry mouth

– Difficulty sleeping/somulance/fatigue

– Abdominal pain, nausea, vomiting/constipation

– Erectile dysfxn/decreased libido/ejaculatory dysfxn

– Urinary hesitancy/retention

– Dysmenorrhea

– Diaphoresis

– Emotional changes

– Increased heart rate/BP

Page 54: ADHD presentation

Wellbutrin

Wellbutrin (buproprion)

– NON STIMULANT

– ADHD: 100 mg po tid

– Dosage forms: 75, 100 mg

– Start 100 mg po bid

– Increase after 3 days

– Maximum dose: 150 mg/dose up to 450 mg/day

– ADHD responds to high doses

Page 55: ADHD presentation

Wellbutrin

Avoid use within 14 days of MAOI

– Seizure Disorder/decreased seizure threshold

– Appetite disturbance

– Head injury

– HTN

– Bipolar

– Hepatic/renal impairment

– Bulemia – may cause e-lyte imbalance

Page 56: ADHD presentation

Wellbutrin

Common side effects:– Agitation/anxiety

– Headache/dizziness

– Nausea/constipation/appetite decrease/weight loss/abd. pain/diarrhea

– Tremor

– Diaphoresis

– Abnormal dreams/insomnia

– Tinnitus

– Palpatations

Page 57: ADHD presentation

Wellbutrin SR

Wellbutrin SR (bupropion)

– NON STIMULANT

– Dosage forms:100, 150, 200 mg ER

– Start 100 mg po qam

– Increase 100 mg/day q week

– Divide dose bid

– Maximum dose: 400 mg/day

– Do not cut, crush or chew

Page 58: ADHD presentation

Wellbutrin SR

Avoid use within 14 days of MAOI

– Seizure Disorder/decreased seizure threshold

– Appetite disturbance

– Head injury

– HTN

– Bipolar

– Hepatic/renal impairment

Page 59: ADHD presentation

Wellbutrin SR

Common side effects:– Agitation/anxiety

– Headache/dizziness

– Nausea/constipation/appetite decrease/weight loss/abd. pain/diarrhea

– Tremor

– Diaphoresis

– Abnormal dreams/insomnia

– Tinnitus

– Palpatations

Page 60: ADHD presentation

Wellbutrin XL

Wellbutrin XL (bupropion)

– NON STIMULANT

– Dosage forms: 150, 300 mg ER

– Start 150 mg po qam

– Increase after 7 days to 300 mg

– Maximum dose: 450 mg/day

– Do not cut, crush or chew

Page 61: ADHD presentation

Wellbutrin XL

Avoid use within 14 days of MAOI

– Seizure Disorder/decreased seizure threshold

– Appetite disturbance

– Head injury

– HTN

– Bipolar

– Hepatic/renal impairment

Page 62: ADHD presentation

Wellbutrin XL

Common side effects:– Agitation/anxiety

– Headache/dizziness

– Nausea/constipation/appetite decrease/weight loss/abd. pain/diarrhea

– Tremor

– Diaphoresis

– Abnormal dreams/insomnia

– Tinnitus

– Palpatations

Page 63: ADHD presentation

Tenex

Tenex (guanfacine)

– NON STIMULANT – OFF LABEL

– Dosage forms: 1, 2 mg

– Start: 0.5 mg po q evening

– Increase 0.5 mg/day q week

– Given bid-qid

– Maximum dose: 4 mg/day

Page 64: ADHD presentation

Tenex

Caution with:

– Elderly

– Hepatic impairment

– Renal impairment

– Cardiovascular disease

– Hypotension

– Avoid abrupt withdrawal – may cause withdrawal sx & rebound HTN

Page 65: ADHD presentation

Tenex

Common side effects:

– Somnolence

– Hypotension

– Dizziness

– Constipation

– Fatigue

– Headache

– Impotence

Page 66: ADHD presentation

Intuniv

Intuniv (guanfacine) – long acting tenex

– 24 hr release

– Dosage forms: 1, 2, 3, 4 mg ER

– Weight dose – 0.05-0.12 mg/kg/day

– Start 1 mg po qd x 1 week then 2 mg po qd

– Hypotension & ^^ HR common

– NO DOSAGE RANGE FOR USE IN ADULTS

Page 67: ADHD presentation

Clonidine

Clonidine

– NON STIMULANT – OFF LABEL

– Dosage forms: 0.1, 0.2, 0.3 mg

– Start: .025-.05 mg po q evening

– Increase 0.025-.05 mg/day q week

– Given bid-qid

– Maximum dose: 0.3 mg/day

Page 68: ADHD presentation

Clonidine

Caution with:

– Elderly

– Hepatic impairment

– Renal impairment

– Cardiovascular disease

– Hypotension

– Avoid abrupt withdrawal – may cause withdrawal sx & rebound HTN

Page 69: ADHD presentation

Clonidine

Common side effects:

– Somnolence

– Hypotension

– Dizziness

– Constipation

– Fatigue

– Headache

– Sexual dysfxn

Page 70: ADHD presentation

Kapvay

Kapvay (clonidine)

– NON STIMULANT – OFF LABEL

– Dosage forms: 0.1, 0.2, mg ER

– Start: 0.1 mg po q evening

– Increase 0.1mg/day q week

– Given qd-bid

– Maximum dose: 0.4mg/day

– Must taper dose when discontinuing

– NO DOSAGE RANGE FOR USE IN ADULTS